Nester C, De Vito A, Prieto S, Kunicki Z, Strenger J, Harrington K
JMIR Aging. 2025; 8:e64033.
PMID: 39903213
PMC: 11812482.
DOI: 10.2196/64033.
Zhou C, Jeryous Fares B, Theriault K, Trinh B, Joseph M, Jauhal T
J Neuropsychol. 2024; 19(1):98-114.
PMID: 39075723
PMC: 11891377.
DOI: 10.1111/jnp.12384.
Kann M, Ruiz-Cardozo M, Brehm S, Bui T, Joseph K, Barot K
Medicina (Kaunas). 2024; 60(2).
PMID: 38399568
PMC: 10890598.
DOI: 10.3390/medicina60020281.
Stites S, Lee B, Rubright J, Harkins K, Mechanic-Hamilton D
Alzheimer Dis Assoc Disord. 2023; 38(1):34-41.
PMID: 38133963
PMC: 10922433.
DOI: 10.1097/WAD.0000000000000595.
Kuhn E, Perrotin A, La Joie R, Touron E, Dautricourt S, Vanhoutte M
Neurology. 2023; 100(24):e2454-e2465.
PMID: 37085328
PMC: 10264050.
DOI: 10.1212/WNL.0000000000207338.
Subjective cognitive decline is associated with a higher risk of objective cognitive decline: A cross-sectional and longitudinal study.
Li W, Yue L, Xiao S
Front Psychiatry. 2022; 13:950270.
PMID: 36245867
PMC: 9558822.
DOI: 10.3389/fpsyt.2022.950270.
Metacognition, cortical thickness, and tauopathy in aging.
Zhuang K, Chen X, Cassady K, Baker S, Jagust W
Neurobiol Aging. 2022; 118:44-54.
PMID: 35868093
PMC: 9979699.
DOI: 10.1016/j.neurobiolaging.2022.06.007.
Evaluating measurement properties of subjective cognitive decline self-reported outcome measures: a systematic review.
Ibnidris A, Robinson J, Stubbs M, Piumatti G, Govia I, Albanese E
Syst Rev. 2022; 11(1):144.
PMID: 35850915
PMC: 9290248.
DOI: 10.1186/s13643-022-02018-y.
Differential Patterns of Domain-Specific Cognitive Complaints and Awareness Across the Alzheimer's Disease Spectrum.
Cacciamani F, Godefroy V, Brambati S, Migliaccio R, Epelbaum S, Montembeault M
Front Aging Neurosci. 2022; 14:811739.
PMID: 35813963
PMC: 9261482.
DOI: 10.3389/fnagi.2022.811739.
Depressive Symptoms Have Distinct Relationships With Neuroimaging Biomarkers Across the Alzheimer's Clinical Continuum.
Moulinet I, Touron E, Mezenge F, Dautricourt S, De La Sayette V, Vivien D
Front Aging Neurosci. 2022; 14:899158.
PMID: 35795235
PMC: 9251580.
DOI: 10.3389/fnagi.2022.899158.
Plasma Levels of Tissue-Type Plasminogen Activator (tPA) in Normal Aging and Alzheimer's Disease: Links With Cognition, Brain Structure, Brain Function and Amyloid Burden.
Tomadesso C, Martinez de Lizarrondo S, Ali C, Landeau B, Mezenge F, Perrotin A
Front Aging Neurosci. 2022; 14:871214.
PMID: 35747448
PMC: 9211060.
DOI: 10.3389/fnagi.2022.871214.
Self-reported word-finding complaints are associated with cerebrospinal fluid amyloid beta and atrophy in cognitively normal older adults.
Montembeault M, Stijelja S, Brambati S
Alzheimers Dement (Amst). 2022; 14(1):e12274.
PMID: 35155731
PMC: 8828990.
DOI: 10.1002/dad2.12274.
Subjective cognitive decline: opposite links to neurodegeneration across the Alzheimer's continuum.
Kuhn E, Perrotin A, Tomadesso C, Andre C, Sherif S, Bejanin A
Brain Commun. 2021; 3(3):fcab199.
PMID: 34704027
PMC: 8421692.
DOI: 10.1093/braincomms/fcab199.
Examining racial disparities in the diagnosis of mild cognitive impairment.
Kiselica A, Johnson E, Lewis K, Trout K
Appl Neuropsychol Adult. 2021; 30(6):749-756.
PMID: 34554020
PMC: 8940745.
DOI: 10.1080/23279095.2021.1976778.
Development of the Subjective Cognitive Decline Scale for Mandarin-Speaking Population.
Tsai H, Wu C, Hsu C, Liu C, Hsu Y
Am J Alzheimers Dis Other Demen. 2021; 36:15333175211038237.
PMID: 34490789
PMC: 10581143.
DOI: 10.1177/15333175211038237.
Item-Level Investigation of Participant and Study Partner Report on the Cognitive Function Index from the A4 Study Screening Data.
Amariglio R, Sikkes S, Marshall G, Buckley R, Gatchel J, Johnson K
J Prev Alzheimers Dis. 2021; 8(3):257-262.
PMID: 34101781
PMC: 8240963.
DOI: 10.14283/jpad.2021.8.
Subtle cognitive impairment as a marker of Alzheimer's pathologies and clinical progression in cognitively normal individuals.
Shen X, Kuo K, Yang Y, Li H, Chen S, Cui M
Alzheimers Dement (Amst). 2021; 13(1):e12198.
PMID: 34095433
PMC: 8158163.
DOI: 10.1002/dad2.12198.
Quantitative informant- and self-reports of subjective cognitive decline predict amyloid beta PET outcomes in cognitively unimpaired individuals independently of age and .
Sanchez-Benavides G, Salvado G, Arenaza-Urquijo E, Grau-Rivera O, Suarez-Calvet M, Mila-Aloma M
Alzheimers Dement (Amst). 2020; 12(1):e12127.
PMID: 33204815
PMC: 7656171.
DOI: 10.1002/dad2.12127.
Quantitative detection and staging of presymptomatic cognitive decline in familial Alzheimer's disease: a retrospective cohort analysis.
OConnor A, Weston P, Pavisic I, Ryan N, Collins J, Lu K
Alzheimers Res Ther. 2020; 12(1):126.
PMID: 33023653
PMC: 7539456.
DOI: 10.1186/s13195-020-00695-2.
The characterisation of subjective cognitive decline.
Jessen F, Amariglio R, Buckley R, van der Flier W, Han Y, Molinuevo J
Lancet Neurol. 2020; 19(3):271-278.
PMID: 31958406
PMC: 7062546.
DOI: 10.1016/S1474-4422(19)30368-0.